Perimenopause is the stretch of years before the final period, when hormone production becomes irregular before it winds down. The frustrating part for many people is that the labs do not always agree with how they feel. That is not a lab error. It is the nature of the transition, and it is why one reading rarely tells the whole story.
Why a single draw can mislead: estradiol levels in perimenopause
Estradiol is the main estrogen of the reproductive years. In a regular cycle it rises and falls on a predictable arc. In perimenopause that arc gets noisy. Estradiol can read high one week and low the next, sometimes higher than in earlier years, sometimes much lower. General reference ranges span widely depending on the phase of the cycle, and they vary by lab and by assay. Because the number fluctuates cycle to cycle, a single estradiol result is a snapshot, not a trend. Two draws weeks apart can look like two different people.
FSH in perimenopause: rising, but erratic
Follicle-stimulating hormone, or FSH, is the brain’s signal to the ovaries. As the ovaries respond less consistently, the brain tends to send a stronger signal, so FSH often trends upward across perimenopause. The catch is that it does not climb in a straight line. FSH can be elevated one month and back down the next, which is why a single high FSH does not confirm the transition and a single normal FSH does not rule it out. Postmenopausal FSH generally settles persistently higher, but during perimenopause the value is a moving target. Timing of the test within the cycle changes what you see.
you are
Add what fits. A physician reviews every order and arranges your consult and labs at checkout. Browse the shop →
The progesterone test and the luteal phase
Progesterone rises after ovulation, during the luteal phase, and is low at other times. A progesterone test is only informative when it is timed to that window, roughly a week before an expected period. In perimenopause, cycles where ovulation does not occur become more common, and progesterone stays low in those months. A low result on the wrong day means little. A well-timed result gives a physician one more piece of context, not a verdict on its own.
Reading the markers together (labs before molecules)
This is the heart of the “labs before molecules” idea: you measure first, and you read the markers in relation to each other rather than one at a time. Estradiol, FSH, and progesterone tell a clearer story together, and they are more useful still when read alongside thyroid markers like TSH and metabolic markers, because thyroid and metabolic shifts can mimic or overlap perimenopausal symptoms. Symptoms matter too. In perimenopause the labs often lag behind how a person feels, so the lived experience and the numbers are read side by side, not ranked against each other. (See the Telos Panel and what we treat.)
What your physician does with these numbers
At Telos, the information you provide and the panel you complete are reviewed by a licensed physician through the affiliated medical group. They consider the timing of each test, how the markers move together, your symptoms, and your history. Hormone therapy may or may not be appropriate, and the timing of testing can change what the results mean, so repeat or cycle-timed testing is sometimes part of the picture. They decide what, if anything, fits, and they may or may not establish a treatment relationship. Nothing here is medical advice. (More on the panel.)